表紙
市場調查報告書

除蟲藥的全球市場:產業分析,規模,佔有率,成長、 趨勢,及預測(2020年∼2030年)

Anthelmintic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

出版商 Transparency Market Research 商品編碼 953592
出版日期 內容資訊 英文 247 Pages
商品交期: 最快1-2個工作天內
價格
除蟲藥的全球市場:產業分析,規模,佔有率,成長、 趨勢,及預測(2020年∼2030年) Anthelmintic Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030
出版日期: 2020年05月28日內容資訊: 英文 247 Pages
簡介

本報告提供全球除蟲藥市場的相關調查,提供市場趨勢和機會,成長及阻礙因素,藥物類別·給藥途徑·用途·目標病原體·流通管道·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

第2章 前提條件與調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
    • 市場定義
    • 產業的演進/發展
  • 概況
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 市場分析與預測(2018-2030)
    • 市場收益預測

第5章 主要洞察

  • 寄生蟲感染疾病的流行病學
  • 主要的產業活動(產品的銷售,核准,收購,合併,合作等)
  • COVID-19的影響

第6章 市場分析:各類藥物

  • 簡介和定義
  • 主要調查結果/開發
  • 市場銷售額預測(2018-2030)
    • 苯並咪唑酮
    • 哌嗪
    • 其他
  • 市場魅力分析

第7章 市場分析:各給藥途徑

  • 簡介和定義
  • 主要調查結果/開發
  • 市場銷售額預測(2018-2030)
    • 口服
    • 注射
  • 市場魅力分析

第8章 市場分析:各用途

  • 簡介和定義
  • 主要調查結果/開發
  • 市場銷售額預測(2018-2030)
    • 動物
  • 市場魅力分析

第9章 市場分析:各目標病原體

  • 簡介和定義
  • 主要調查結果/開發
  • 市場銷售額預測(2018-2030)
    • Ascaris Lumbricoides (Roundworm)
    • Trichuris Trichiura (Whipworm
    • Enterobius Vermicularis (Pinworm)
    • Ancylostoma Duodenale (Hookworm)
    • 其他
  • 市場魅力分析

第10章 市場分析:各流通管道

  • 簡介和定義
  • 主要調查結果/開發
  • 市場銷售額預測(2018-2030)
    • 醫院藥局
    • 零售藥局
    • 線上藥局
    • 動物醫藥局
    • 獸醫醫院·診療所
  • 市場魅力分析

第11章 市場分析:各地區

  • 主要調查結果
  • 市場銷售額預測(2018-2030)
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場魅力分析

第12章 北美

  • 簡介
    • 主要調查結果
  • 各藥物類別(2018-2030)
  • 各給藥途徑(2018-2030)
  • 各用途(2018-2030)
  • 各標的病原體(2018-2030)
  • 各流通管道(2018-2030)
  • 各國(2018-2030)
    • 美國
    • 加拿大
  • 市場魅力分析

第13章 歐洲

第14章 亞太地區

第15章 南美

第16章 中東·非洲

第17章 競爭情形

  • 市場參與企業: 競爭矩陣(企業的各階層與規模)
  • 企業簡介
    • Novartis AG
    • Zoetis, Inc.
    • Amneal Pharmaceuticals Inc.
    • Cipla Inc.
    • Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
    • Sun Pharmaceutical Industries Ltd
    • GlaxoSmithKline plc
    • Bayer AG
    • Merck & Co. Inc. (Intervet Inc.)
    • Boehringer Ingelheim International GmbH
目錄
Product Code: TMRGL50688

Title:
Anthelmintic Drugs Market (Drug Class: Benzimidazoles, Piperazine, and Others; Route of Administration: Oral and Injectable; Application: Human [Parenchymal Neurocysticercosis and Gastrointestinal Infections] and Animal; Target Pathogen: Ascaris Lumbricoides [Roundworm], Trichuris Trichiura [Whipworm], Enterobius Vermicularis [Pinworm], Ancylostoma Duodenale [Hookworm], and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Veterinary Pharmacies, and Veterinary Hospitals & Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030.

Scope of the Report

TMR's report on the global anthelmintic drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period 2020 to 2030 The report provides the overall revenue of the global anthelmintic drugs market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global anthelmintic drugs market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global anthelmintic drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global anthelmintic drugs market.

The report delves into the competition landscape of the global anthelmintic drugs market. Key players operating in the global anthelmintic drugs market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global anthelmintic drugs market report.

Key Questions Answered:

  • What is the sales/revenue generated by the global anthelmintic drugs market across all the regions during the forecast period?
  • What are the key trends in the global anthelmintic drugs market?
  • What are the major drivers, restraints, and opportunities in the global market?
  • Which region is set to expand at the fastest CAGR during the forecast period?
  • Which segment will have the highest revenue globally in 2030 and which drug class will expand at the fastest CAGR during the forecast period?

Research Objectives and Research Approach

The comprehensive report on the global anthelmintic drugs market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global anthelmintic drugs market. It is followed by market introduction, market dynamics, and an overview of the global anthelmintic drugs market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the anthelmintic drugs market. The next section of the global anthelmintic drugs market report highlights the USPs, which include epidemiology of helminthic infections across globe, key industry events (product launches, approvals, acquisitions, mergers, collaborations, etc.), and impact of COVID-19 on the anthelmintic drugs market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key anthelmintic drugs manufacturers has been mapped to ascertain the size of the global anthelmintic drugs market in terms of value. The forecast presented here assesses the total revenue generated in the anthelmintic drugs market. In order to provide an accurate forecast, we initiated by sizing up the current anthelmintic drugs market with the help of the parent market.

The report analyzes the global anthelmintic drugs market in terms of drug class, route of administration, application, target pathogen, distribution channel, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global anthelmintic drugs market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Anthelmintic Drugs Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Market Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Anthelmintic Drugs Market Analysis and Forecast, 2018-2030
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Epidemiology of Helminthic Infections
  • 5.2. Key Industry Events (Product Launch, Approval, Acquisition, Merger, Collaboration, etc.)
  • 5.3. Impact of COVID-19 on Anthelmintic Drugs Market

6. Global Anthelmintic Drugs Market Analysis and Forecast, by Drug Class

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018-2030
    • 6.3.1. Benzimidazoles
    • 6.3.2. Piperazine
    • 6.3.3. Others
  • 6.4. Market Attractiveness Analysis, by Drug Class

7. Global Anthelmintic Drugs Market Analysis and Forecast, by Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018-2030
    • 7.3.1. Oral
    • 7.3.2. Injectable
  • 7.4. Market Attractiveness Analysis, by Route of Administration

8. Global Anthelmintic Drugs Market Analysis and Forecast, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Anthelmintic Drugs Market Value Forecast, by Application, 2018-2030
    • 8.3.1. Human
      • 8.3.1.1. Parenchymal Neurocysticercosis
      • 8.3.1.2. Gastrointestinal Infections
    • 8.3.2. Animal
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Anthelmintic Drugs Market Analysis and Forecast, by Target Pathogen

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018-2030
    • 9.3.1. Ascaris Lumbricoides (Roundworm)
    • 9.3.2. Trichuris Trichiura (Whipworm
    • 9.3.3. Enterobius Vermicularis (Pinworm)
    • 9.3.4. Ancylostoma Duodenale (Hookworm)
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis, by Target Pathogen

10. Global Anthelmintic Drugs Market Analysis and Forecast, by Distribution Channel

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018-2030
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Pharmacies
    • 10.3.4. Veterinary Pharmacies
    • 10.3.5. Veterinary Hospitals & Clinics
  • 10.4. Market Attractiveness Analysis, by Distribution Channel

11. Global Anthelmintic Drugs Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Anthelmintic Drugs Market Value Forecast, by Region
    • 11.2.1. Europe
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness Analysis, by Region

12. North America Anthelmintic Drugs Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. North America Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018-2030
    • 12.2.1. Benzimidazoles
    • 12.2.2. Piperazine
    • 12.2.3. Others
  • 12.3. North America Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018-2030
    • 12.3.1. Oral
    • 12.3.2. Injectable
  • 12.4. North America Anthelmintic Drugs Market Value Forecast, by Application, 2018-2030
    • 12.4.1. Human
      • 12.4.1.1. Parenchymal Neurocysticercosis
      • 12.4.1.2. Gastrointestinal Infections
    • 12.4.2. Animal
  • 12.5. North America Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018-2030
    • 12.5.1. Ascaris Lumbricoides (Roundworm)
    • 12.5.2. Trichuris Trichiura (Whipworm
    • 12.5.3. Enterobius Vermicularis (Pinworm)
    • 12.5.4. Ancylostoma Duodenale (Hookworm)
    • 12.5.5. Others
  • 12.6. North America Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018-2030
    • 12.6.1. Hospital Pharmacies
    • 12.6.2. Retail Pharmacies
    • 12.6.3. Online Pharmacies
    • 12.6.4. Veterinary Pharmacies
    • 12.6.5. Veterinary Hospitals & Clinics
  • 12.7. North America Anthelmintic Drugs Market Value Forecast, by Country, 2018-2030
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. North America Anthelmintic Drugs Market Attractiveness Analysis
    • 12.8.1. By Drug Class
    • 12.8.2. By Route of Administration
    • 12.8.3. By Application
    • 12.8.4. By Target Pathogen
    • 12.8.5. By Distribution Channel
    • 12.8.6. By Country

13. Europe Anthelmintic Drugs Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Europe Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018-2030
    • 13.2.1. Benzimidazoles
    • 13.2.2. Piperazine
    • 13.2.3. Others
  • 13.3. Europe Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018-2030
    • 13.3.1. Oral
    • 13.3.2. Injectable
  • 13.4. Europe Anthelmintic Drugs Market Value Forecast, by Application, 2018-2030
    • 13.4.1. Human
      • 13.4.1.1. Parenchymal Neurocysticercosis
      • 13.4.1.2. Gastrointestinal Infections
    • 13.4.2. Animal
  • 13.5. Europe Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018-2030
    • 13.5.1. Ascaris Lumbricoides (Roundworm)
    • 13.5.2. Trichuris Trichiura (Whipworm
    • 13.5.3. Enterobius Vermicularis (Pinworm)
    • 13.5.4. Ancylostoma Duodenale (Hookworm)
    • 13.5.5. Others
  • 13.6. Europe Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018-2030
    • 13.6.1. Hospital Pharmacies
    • 13.6.2. Retail Pharmacies
    • 13.6.3. Online Pharmacies
    • 13.6.4. Veterinary Pharmacies
    • 13.6.5. Veterinary Hospitals & Clinics
  • 13.7. Europe Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018-2030
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Spain
    • 13.7.5. Italy
    • 13.7.6. Rest of Europe
  • 13.8. Europe Anthelmintic Drugs Market Attractiveness Analysis
    • 13.8.1. By Drug Class
    • 13.8.2. By Route of Administration
    • 13.8.3. By Application
    • 13.8.4. By Target Pathogen
    • 13.8.5. By Distribution Channel
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Anthelmintic Drugs Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018-2030
    • 14.2.1. Benzimidazoles
    • 14.2.2. Piperazine
    • 14.2.3. Others
  • 14.3. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018-2030
    • 14.3.1. Oral
    • 14.3.2. Injectable
  • 14.4. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Application, 2018-2030
    • 14.4.1. Human
      • 14.4.1.1. Parenchymal Neurocysticercosis
      • 14.4.1.2. Gastrointestinal Infections
    • 14.4.2. Animal
  • 14.5. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018-2030
    • 14.5.1. Ascaris Lumbricoides (Roundworm)
    • 14.5.2. Trichuris Trichiura (Whipworm
    • 14.5.3. Enterobius Vermicularis (Pinworm)
    • 14.5.4. Ancylostoma Duodenale (Hookworm)
    • 14.5.5. Others
  • 14.6. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018-2030
    • 14.6.1. Hospital Pharmacies
    • 14.6.2. Retail Pharmacies
    • 14.6.3. Online Pharmacies
    • 14.6.4. Veterinary Pharmacies
    • 14.6.5. Veterinary Hospitals & Clinics
  • 14.7. Asia Pacific Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018-2030
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis
    • 14.8.1. By Drug Class
    • 14.8.2. By Route of Administration
    • 14.8.3. By Application
    • 14.8.4. By Target Pathogen
    • 14.8.5. By Distribution Channel
    • 14.8.6. By Country/Sub-region

15. Latin America Anthelmintic Drugs Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Latin America Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018-2030
    • 15.2.1. Benzimidazoles
    • 15.2.2. Piperazine
    • 15.2.3. Others
  • 15.3. Latin America Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018-2030
    • 15.3.1. Oral
    • 15.3.2. Injectable
  • 15.4. Latin America Anthelmintic Drugs Market Value Forecast, by Application, 2018-2030
    • 15.4.1. Human
      • 15.4.1.1. Parenchymal Neurocysticercosis
      • 15.4.1.2. Gastrointestinal Infections
    • 15.4.2. Animal
  • 15.5. Latin America Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018-2030
    • 15.5.1. Ascaris Lumbricoides (Roundworm)
    • 15.5.2. Trichuris Trichiura (Whipworm
    • 15.5.3. Enterobius Vermicularis (Pinworm)
    • 15.5.4. Ancylostoma Duodenale (Hookworm)
    • 15.5.5. Others
  • 15.6. Latin America Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018-2030
    • 15.6.1. Hospital Pharmacies
    • 15.6.2. Retail Pharmacies
    • 15.6.3. Online Pharmacies
    • 15.6.4. Veterinary Pharmacies
    • 15.6.5. Veterinary Hospitals & Clinics
  • 15.7. Latin America Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018-2030
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Latin America Anthelmintic Drugs Market Attractiveness Analysis
    • 15.8.1. By Drug Class
    • 15.8.2. By Route of Administration
    • 15.8.3. By Application
    • 15.8.4. By Target Pathogen
    • 15.8.5. By Distribution Channel
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Anthelmintic Drugs Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Drug Class, 2018-2030
    • 16.2.1. Benzimidazoles
    • 16.2.2. Piperazine
    • 16.2.3. Others
  • 16.3. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Route of Administration, 2018-2030
    • 16.3.1. Oral
    • 16.3.2. Injectable
  • 16.4. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Application, 2018-2030
    • 16.4.1. Human
      • 16.4.1.1. Parenchymal Neurocysticercosis
      • 16.4.1.2. Gastrointestinal Infections
    • 16.4.2. Animal
  • 16.5. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Target Pathogen, 2018-2030
    • 16.5.1. Ascaris Lumbricoides (Roundworm)
    • 16.5.2. Trichuris Trichiura (Whipworm
    • 16.5.3. Enterobius Vermicularis (Pinworm)
    • 16.5.4. Ancylostoma Duodenale (Hookworm)
    • 16.5.5. Others
  • 16.6. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Distribution Channel, 2018-2030
    • 16.6.1. Hospital Pharmacies
    • 16.6.2. Retail Pharmacies
    • 16.6.3. Online Pharmacies
    • 16.6.4. Veterinary Pharmacies
    • 16.6.5. Veterinary Hospitals & Clinics
  • 16.7. Middle East & Africa Anthelmintic Drugs Market Value Forecast, by Country/Sub-region, 2018-2030
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis
    • 16.8.1. By Drug Class
    • 16.8.2. By Route of Administration
    • 16.8.3. By Application
    • 16.8.4. By Target Pathogen
    • 16.8.5. By Distribution Channel
    • 16.8.6. By Country/Sub-region

17. Competitive Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Company Profiles
    • 17.2.1. Novartis AG
      • 17.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.1.2. Financial Overview
      • 17.2.1.3. Product Portfolio
      • 17.2.1.4. Strategic Overview
      • 17.2.1.5. SWOT Analysis
    • 17.2.2. Zoetis, Inc.
      • 17.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.2.2. Financial Overview
      • 17.2.2.3. Product Portfolio
      • 17.2.2.4. Strategic Overview
      • 17.2.2.5. SWOT Analysis
    • 17.2.3. Amneal Pharmaceuticals Inc.
      • 17.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.3.2. Financial Overview
      • 17.2.3.3. Product Portfolio
      • 17.2.3.4. Strategic Overview
      • 17.2.3.5. SWOT Analysis
    • 17.2.4. Cipla Inc.
      • 17.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.4.2. Financial Overview
      • 17.2.4.3. Product Portfolio
      • 17.2.4.4. Strategic Overview
      • 17.2.4.5. SWOT Analysis
    • 17.2.5. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
      • 17.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.5.2. Financial Overview
      • 17.2.5.3. Product Portfolio
      • 17.2.5.4. Strategic Overview
      • 17.2.5.5. SWOT Analysis
    • 17.2.6. Sun Pharmaceutical Industries Ltd
      • 17.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.6.2. Financial Overview
      • 17.2.6.3. Product Portfolio
      • 17.2.6.4. Strategic Overview
      • 17.2.6.5. SWOT Analysis
    • 17.2.7. GlaxoSmithKline plc
      • 17.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.7.2. Financial Overview
      • 17.2.7.3. Product Portfolio
      • 17.2.7.4. Strategic Overview
      • 17.2.7.5. SWOT Analysis
    • 17.2.8. Bayer AG
      • 17.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.8.2. Financial Overview
      • 17.2.8.3. Product Portfolio
      • 17.2.8.4. Strategic Overview
      • 17.2.8.5. SWOT Analysis
    • 17.2.9. Merck & Co. Inc. (Intervet Inc.)
      • 17.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.9.2. Financial Overview
      • 17.2.9.3. Product Portfolio
      • 17.2.9.4. Strategic Overview
      • 17.2.9.5. SWOT Analysis
    • 17.2.10. Boehringer Ingelheim International GmbH
      • 17.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.10.2. Financial Overview
      • 17.2.10.3. Product Portfolio
      • 17.2.10.4. Strategic Overview
      • 17.2.10.5. SWOT Analysis

List of Tables

  • Table 01: Europe Anthelmintic Drugs Market - Prevalence
  • Table 02: Europe Anthelmintic Drugs Market - Prevalence
  • Table 03: Global Anthelmintic Drugs Market Forecast, by Drug Class
  • Table 04: Global Anthelmintic Drugs Market Forecast, by Route of Administration
  • Table 05: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2020-2030
  • Table 06: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2020-2030
  • Table 07: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018-2030
  • Table 08: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 09: Global Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 10: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country, 2018?2030
  • Table 11: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018?2030
  • Table 12: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2018?2030
  • Table 13: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018?2030
  • Table 14: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018?2030
  • Table 15: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018?2030
  • Table 16: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018?2030
  • Table 17: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018?2030
  • Table 18: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018?2030
  • Table 19: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route Of Administration, 2018?2030
  • Table 20: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018?2030
  • Table 21: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018?2030
  • Table 22: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018?2030
  • Table 23: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018?2030
  • Table 24: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 25: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 26: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route Of Administration, 2018-2030
  • Table 27: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 28: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human Application, 2018-2030
  • Table 29: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018-2030
  • Table 30: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 31: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 32: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 33: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 34: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 35: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018-2030
  • Table 36: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018-2030
  • Table 37: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 38: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 39: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Drug Class, 2018-2030
  • Table 40: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Route of Administration, 2018-2030
  • Table 41: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Application, 2018-2030
  • Table 42: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Human, 2018-2030
  • Table 43: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Target Pathogen, 2018-2030
  • Table 44: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030

List of Figures

  • Figure 01: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y (%) Forecast, 2018-2030
  • Figure 02: Global Anthelmintic Drugs Market Value Share, by Drug Class, 2019
  • Figure 03: Global Anthelmintic Drugs Market Value Share, by Route of Administration, 2019
  • Figure 05: Global Anthelmintic Drugs Market Value Share, by Target Pathogen, 2019
  • Figure 04: Global Anthelmintic Drugs Market Value Share, by Application, 2019
  • Figure 06: Global Anthelmintic Drugs Market Value Share, by Distribution Channel, 2019
  • Figure 07: Global Anthelmintic Drugs Market Value Share, by Region, 2019
  • Figure 08: North America Anthelmintic Drugs Market - Prevalence
  • Figure 09: North America Anthelmintic Drugs Market - Prevalence
  • Figure 10: Asia Pacific Anthelmintic Drugs Market - Prevalence
  • Figure 11: Latin America Anthelmintic Drugs Market - Prevalence
  • Figure 12: Middle East & Africa Anthelmintic Drugs Market - Prevalence
  • Figure 13: Key Industry Developments - Anthelmintic Drugs Market
  • Figure 14: Global Anthelmintic Drugs Market Value Share Analysis, by Drug Class, 2019 and 2030
  • Figure 15: Global Anthelmintic Drugs Market Attractiveness Analysis, by Drug Class, 2020-2030
  • Figure 16: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Benzimidazoles, 2020-2030
  • Figure 17: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Piperazine, 2020-2030
  • Figure 18: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2020-2030
  • Figure 19: Global Anthelmintic Drugs Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 20: Global Anthelmintic Drugs Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 21: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Oral, 2020-2030
  • Figure 22: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Injectable, 2020-2030
  • Figure 23: Global Anthelmintic Drugs Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 24: Global Anthelmintic Drugs Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 25: Global Anthelmintic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Human, 2020-2030
  • Figure 26: Global Anthelmintic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Animal, 2020-2030
  • Figure 27: Global Anthelmintic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenchymal Neurocysticercosis, 2020-2030
  • Figure 28: Global Anthelmintic Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gastrointestinal Infections, 2020-2030
  • Figure 29: Global Anthelmintic Drugs Market Value Share Analysis, by Target Pathogen, 2019 and 2030
  • Figure 30: Global Anthelmintic Drugs Market Attractiveness Analysis, by Target Pathogen, 2020-2030
  • Figure 31: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Ascaris Lumbricoides (Roundworm), 2020-2030
  • Figure 32: Global Anthelmintic Drugs Market value (US$ Mn) and Y-o-Y Growth (%), by Trichuris Trichiura (Whipworm), 2020-2030
  • Figure 33: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Enterobius Vermicularis (Pinworm), 2020-2030
  • Figure 34: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Ancylostoma Duodenale (Hookworm), 2020-2030
  • Figure 35: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2020-2030
  • Figure 36: Global Anthelmintic Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 37: Global Anthelmintic Drugs Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 38: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2020-2030
  • Figure 39: Global Anthelmintic Drugs Market value (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2020-2030
  • Figure 40: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2020-2030
  • Figure 41: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Veterinary Pharmacies, 2020-2030
  • Figure 42: Global Anthelmintic Drugs Market Value (US$ Mn) and Y-o-Y Growth (%), by Veterinary Hospitals and Clinics, 2020-2030
  • Figure 43: Global Anthelmintic Drugs Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 44: Global Anthelmintic Drugs Market Attractiveness Analysis, by Region, 2020-2030
  • Figure 45: North America Anthelmintic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018?2030
  • Figure 46: North America Anthelmintic Drugs Market Value Share Analysis, by Country, 2019 and 2030
  • Figure 47: North America Anthelmintic Drugs Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 48: North America Anthelmintic Drugs Market Value Share Analysis, by Drug Class, 2019 and 2030
  • Figure 49: North America Anthelmintic Drugs Market Attractiveness Analysis, by Drug Class, 2020-2030
  • Figure 50: North America Anthelmintic Drugs Market Value Share Analysis, by Route Of Administration, 2019 and 2030
  • Figure 51: North America Anthelmintic Drugs Market Attractiveness Analysis, by Route Of Administration, 2020-2030
  • Figure 52: North America Anthelmintic Drugs Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 53: North America Anthelmintic Drugs Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 54: North America Anthelmintic Drugs Market Value Share Analysis, by Target Pathogen, 2019 and 2030
  • Figure 55: North America Anthelmintic Drugs Market Attractiveness Analysis, by Target Pathogen, 2020-2030
  • Figure 56: North America Anthelmintic Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 57: North America Anthelmintic Drugs Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 58: Europe Anthelmintic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018?2030
  • Figure 59: Europe Anthelmintic Drugs Market Value Share Analysis, by Country, 2019 and 2030
  • Figure 60: Europe Anthelmintic Drugs Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 61: Europe Anthelmintic Drugs Market Value Share Analysis, by Drug Class, 2019 and 2030
  • Figure 62: Europe Anthelmintic Drugs Market Attractiveness Analysis, by Drug Class, 2020-2030
  • Figure 63: Europe Anthelmintic Drugs Market Value Share Analysis, by Route Of Administration, 2019 and 2030
  • Figure 64: Europe Anthelmintic Drugs Market Attractiveness Analysis, by Route Of Administration, 2020-2030
  • Figure 65: Europe Anthelmintic Drugs Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 66: Europe Anthelmintic Drugs Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 67: Europe Anthelmintic Drugs Market Value Share Analysis, by Target Pathogen, 2019 and 2030
  • Figure 68: Europe Anthelmintic Drugs Market Attractiveness Analysis, by Target Pathogen, 2020-2030
  • Figure 69: Europe Anthelmintic Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 70: Europe Anthelmintic Drugs Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 71: Asia Pacific Anthelmintic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 72: Asia Pacific Anthelmintic Drugs Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 73: Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 74: Asia Pacific Anthelmintic Drugs Market Value Share Analysis, by Drug Class, 2019 and 2030
  • Figure 75: Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis, by Drug Class, 2020-2030
  • Figure 76: Asia Pacific Anthelmintic Drugs Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 77: Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 78: Asia Pacific Anthelmintic Drugs Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 79: Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 80: Asia Pacific Anthelmintic Drugs Market Value Share Analysis, by Target Pathogen, 2019 and 2030
  • Figure 81: Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis, by Target Pathogen, 2020-2030
  • Figure 82: Asia Pacific Anthelmintic Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 83: Asia Pacific Anthelmintic Drugs Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 84: Latin America Anthelmintic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 85: Latin America Anthelmintic Drugs Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 86: Latin America Anthelmintic Drugs Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 87: Latin America Anthelmintic Drugs Market Value Share Analysis, by Drug Class, 2019 and 2030
  • Figure 88: Latin America Anthelmintic Drugs Market Attractiveness Analysis, by Drug Class, 2020-2030
  • Figure 89: Latin America Anthelmintic Drugs Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 90: Latin America Anthelmintic Drugs Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 91: Latin America Anthelmintic Drugs Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 92: Latin America Anthelmintic Drugs Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 93: Latin America Anthelmintic Drugs Market Value Share Analysis, by Target Pathogen, 2019 and 2030
  • Figure 94: Latin America Anthelmintic Drugs Market Attractiveness Analysis, by Target Pathogen, 2020-2030
  • Figure 95: Latin America Anthelmintic Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 96: Latin America Anthelmintic Drugs Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 97: Middle East & Africa Anthelmintic Drugs Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018-2030
  • Figure 98: Middle East & Africa Anthelmintic Drugs Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 99: Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 100: Middle East & Africa Anthelmintic Drugs Market Value Share Analysis, by Drug Class, 2019 and 2030
  • Figure 101: Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis, by Drug Class, 2020-2030
  • Figure 102: Middle East & Africa Anthelmintic Drugs Market Value Share Analysis, by Route of Administration, 2019 and 2030
  • Figure 103: Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis, by Route of Administration, 2020-2030
  • Figure 104: Middle East & Africa Anthelmintic Drugs Market Value Share Analysis, by Application, 2019 and 2030
  • Figure 105: Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis, by Application, 2020-2030
  • Figure 106: Middle East & Africa Anthelmintic Drugs Market Value Share Analysis, by Target Pathogen, 2019 and 2030
  • Figure 107: Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis, by Target Pathogen, 2020-2030
  • Figure 108: Middle East & Africa Anthelmintic Drugs Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 109: Middle East & Africa Anthelmintic Drugs Market Attractiveness Analysis, by Distribution Channel, 2020-2030